Sarah Leatherman

1.5k total citations
31 papers, 743 citations indexed

About

Sarah Leatherman is a scholar working on Cardiology and Cardiovascular Medicine, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah Leatherman has authored 31 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in General Health Professions and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah Leatherman's work include Blood Pressure and Hypertension Studies (5 papers), Ethics in Clinical Research (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Sarah Leatherman is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Ethics in Clinical Research (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Sarah Leatherman collaborates with scholars based in United States, Canada and Netherlands. Sarah Leatherman's co-authors include Mary T. Brophy, Robert Lew, John A. Hermos, Jennifer R. Fonda, David Gagnon, Matthew J. Miller, Kelly Cho, Catherine Barber, Ted R. Mikuls and Edward Keystone and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Sarah Leatherman

26 papers receiving 723 citations

Peers

Countries citing papers authored by Sarah Leatherman

Since Specialization

Citations

This map shows the geographic impact of Sarah Leatherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Leatherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Leatherman more than expected).

Fields of papers citing papers by Sarah Leatherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Leatherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Leatherman. The network helps show where Sarah Leatherman may publish in the future.

Co-authorship network of co-authors of Sarah Leatherman

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Leatherman. A scholar is included among the top collaborators of Sarah Leatherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Leatherman. Sarah Leatherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension 2024 ·JAMA Network Open ·Areef Ishani, Cynthia Hau, Srihari Raju, (unknown), Peter Glassman, Addison A. Taylor, Ryan Ferguson, William C. Cushman, Sarah Leatherman	1
2	Strategies for secondary use of real-world clinical and administrative data for outcome ascertainment in pragmatic clinical trials 2024 ·Journal of Biomedical Informatics ·Cynthia Hau, Patricia Woods, (unknown), Srihari Raju, Liang Zhu, Patrick R. Alba, William C. Cushman, Peter Glassman, Areef Ishani, Addison A. Taylor, Ryan Ferguson, Sarah Leatherman	2
3	The impact of COVID-19 on a large pragmatic clinical trial embedded in primary care 2023 ·Contemporary Clinical Trials ·Sarah Leatherman, Cynthia Hau, (unknown), Peter Glassman, Addison A. Taylor, Ryan Ferguson, William C. Cushman, Areef Ishani	2
4	Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation 2023 ·Contemporary Clinical Trials ·(unknown), Ryan Ferguson, Patricia Woods, (unknown), (unknown), (unknown), Sara Schiller, Colleen Shannon, Mary T. Brophy, Paul A. Monach, Sarah Leatherman, Westyn Branch‐Elliman	0
5	A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials 2023 ·JAMA Network Open ·Cynthia Hau, Jimmy T. Efird, Sarah Leatherman, (unknown), Peter Glassman, Patricia Woods, Areef Ishani, William C. Cushman, Ryan Ferguson	2
6	Telephone informed consent in a pragmatic point-of-care clinical trial embedded in primary care 2023 ·Contemporary Clinical Trials ·(unknown), Sarah Leatherman, (unknown), Peter Glassman, Ryan Ferguson, William C. Cushman, Areef Ishani	1
7	Ascertainment of stroke from administrative data to support a pragmatic embedded clinical trial 2023 ·Contemporary Clinical Trials ·Srihari Raju, Cynthia Hau, Patricia Woods, (unknown), (unknown), Jacob G. McPherson, (unknown), Areef Ishani, Ryan Ferguson, Sarah Leatherman	4
8	Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project 2022 ·Contemporary Clinical Trials ·Areef Ishani, Sarah Leatherman, Patricia Woods, Cynthia Hau, (unknown), Robert Lew, Addison A. Taylor, Peter Glassman, Mary T. Brophy, Louis D. Fiore, Ryan Ferguson, William C. Cushman	13
9	Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial 2021 ·Contemporary Clinical Trials Communications ·Patricia Woods, (unknown), Paul A. Monach, (unknown), Sara Schiller, (unknown), Sarah Leatherman, Ryan Ferguson, Westyn Branch‐Elliman	8
10	Rapid implementation of a modular clinical trial informatics solution for COVID-19 research 2021 ·Informatics in Medicine Unlocked ·Rupali P. Dhond, (unknown), Sarah Leatherman, (unknown), (unknown), (unknown), Frank Meng, Ryan Ferguson, Mary T. Brophy, Nhan Do	0
11	ProjectFlow: a configurable workflow management application for point of care research 2021 ·JAMIA Open ·Rupali P. Dhond, (unknown), (unknown), (unknown), Sergey Goryachev, (unknown), Sarah Leatherman, Tori Anglin-Foote, Qingzhu Liu, (unknown), (unknown), (unknown), Ryan Ferguson, Mary T. Brophy, (unknown), Scott L. DuVall, Nhan Do	6
12	RESIDUAL CARDIOVASCULAR RISK IN U.S. VETERANS WITH MODERATELY-ELEVATED BASELINE TRIGLYCERIDES ACROSS THE CARDIOVASCULAR RISK SPECTRUM 2020 ·Journal of the American College of Cardiology ·Sarah Leatherman, Ryan Ferguson, Cynthia Hau, Craig Granowitz, Kelly Harrington, Sephy Philip, Peter P. Tóth, Deepak L. Bhatt, William E. Boden	1
13	INCREASED RESIDUAL CARDIOVASCULAR RISK IN US VETERANS AND MONERATELY-ELEVATED BASELINE TRIGLYCERIDES AND WELL-CONTROLLED LDL-C LEVELS ON STATINS 2019 ·Journal of the American College of Cardiology ·Sarah Leatherman, Ryan Ferguson, Isabelle R. Weir, Cynthia Hau, Craig Granowitz, Kelly Harrington, Sephy Philip, Peter P. Tóth, Deepak L. Bhatt, William E. Boden	2
14	A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials 2018 ·Arthritis Care & Research ·Maarten Boers, Jasvinder A. Singh, Stacey S. Cofield, S. Louis Bridges, Larry W. Moreland, James R. O’Dell, (unknown), Sarah Leatherman, Jeffrey R. Curtis	3
15	Identification of Acute Decompensated Heart Failure Hospitalizations Using Administrative Data 2017 ·The American Journal of Cardiology ·Hans Huang, (unknown), Srihari Raju, Jon Reich, Sarah Leatherman, Katherine Armstrong, Patricia Woods, Ryan Ferguson, Louis D. Fiore, Frank A. Lederle	16
16	The Rivas Cohort Study: design and baseline characteristics of a Nicaraguan cohort 2016 ·BMC Nephrology ·(unknown), (unknown), (unknown), Ryan Ferguson, Sarah Leatherman, (unknown), James S. Kaufman, (unknown), Daniel R. Brooks, Juan José Amador, (unknown), (unknown), (unknown), (unknown), Amos Lichtman, (unknown), Matthew Lawlor, (unknown), Rulan S. Parekh, Louis D. Fiore	2
17	The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments 2015 ·Drug Metabolism and Disposition ·L. Haupt, Faraz Kazmi, Brian W. Ogilvie, David B. Buckley, Brian D. Smith, Sarah Leatherman, Brandy L. Paris, (unknown), Andrew Parkinson	50
18	Prescription Opioid Duration of Action and the Risk of Unintentional Overdose Among Patients Receiving Opioid Therapy 2015 ·JAMA Internal Medicine ·Matthew J. Miller, Catherine Barber, Sarah Leatherman, Jennifer R. Fonda, John A. Hermos, Kelly Cho, David Gagnon	192
19	Posttraumatic stress disorder, depression, and non-fatal intentional self-harm in Massachusetts Veterans 2014 ·Injury Epidemiology ·Jaimie L. Gradus, Sarah Leatherman, (unknown), Ryan Ferguson, Matthew Miller	10
20	Therapies for Active Rheumatoid Arthritis after Methotrexate Failure 2013 ·New England Journal of Medicine ·James R. O’Dell, Ted R. Mikuls, Thomas H. Taylor, Vandana Ahluwalia, Mary T. Brophy, Stuart Warren, Robert Lew, Amy C. Cannella, Gary Kunkel, Ciaran S. Phibbs, Aslam H. Anis, Sarah Leatherman, Edward Keystone	263

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact